Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications
Metabolomics is defined as the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification. It is an "omics" technique that is situated downstream of genomics, transcriptomics and proteomics. Metabolomic...
Saved in:
| Published in | World journal of gastroenterology : WJG Vol. 22; no. 1; pp. 417 - 426 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
United States
Baishideng Publishing Group Co. Limited
07.01.2016
Baishideng Publishing Group Inc |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Metabolomics is defined as the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification. It is an "omics" technique that is situated downstream of genomics, transcriptomics and proteomics. Metabolomics is recognized as a promising technique in the field of systems biology for the evaluation of global metabolic changes. During the last decade, metabolomics approaches have become widely used in the study of liver diseases for the detection of early biomarkers and altered metabolic pathways. It is a powerful technique to improve our pathophysiological knowledge of various liver diseases. It can be a useful tool to help clinicians in the diagnostic process especially to distinguish malignant and non-malignant liver disease as well as to determine the etiology or severity of the liver disease. It can also assess therapeutic response or predict drug induced liver injury. Nevertheless, the usefulness of metabolomics is often not understood by clinicians, especially the concept of metabolomics profiling or fingerprinting. In the present work, after a concise description of the different techniques and processes used in metabolomics, we will review the main research on this subject by focusing specifically on in vitro proton nuclear magnetic resonance spectroscopy based metabolomics approaches in human studies. We will first consider the clinical point of view enlighten physicians on this new approach and emphasis its future use in clinical "routine". |
|---|---|
| AbstractList | Metabolomics is defined as the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification. It is an "omics" technique that is situated downstream of genomics, transcriptomics and proteomics. Metabolomics is recognized as a promising technique in the field of systems biology for the evaluation of global metabolic changes. During the last decade, metabolomics approaches have become widely used in the study of liver diseases for the detection of early biomarkers and altered metabolic pathways. It is a powerful technique to improve our pathophysiological knowledge of various liver diseases. It can be a useful tool to help clinicians in the diagnostic process especially to distinguish malignant and non-malignant liver disease as well as to determine the etiology or severity of the liver disease. It can also assess therapeutic response or predict drug induced liver injury. Nevertheless, the usefulness of metabolomics is often not understood by clinicians, especially the concept of metabolomics profiling or fingerprinting. In the present work, after a concise description of the different techniques and processes used in metabolomics, we will review the main research on this subject by focusing specifically on in vitro proton nuclear magnetic resonance spectroscopy based metabolomics approaches in human studies. We will first consider the clinical point of view enlighten physicians on this new approach and emphasis its future use in clinical "routine". Metabolomics is defined as the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification. It is an “omics” technique that is situated downstream of genomics, transcriptomics and proteomics. Metabolomics is recognized as a promising technique in the field of systems biology for the evaluation of global metabolic changes. During the last decade, metabolomics approaches have become widely used in the study of liver diseases for the detection of early biomarkers and altered metabolic pathways. It is a powerful technique to improve our pathophysiological knowledge of various liver diseases. It can be a useful tool to help clinicians in the diagnostic process especially to distinguish malignant and non-malignant liver disease as well as to determine the etiology or severity of the liver disease. It can also assess therapeutic response or predict drug induced liver injury. Nevertheless, the usefulness of metabolomics is often not understood by clinicians, especially the concept of metabolomics profiling or fingerprinting. In the present work, after a concise description of the different techniques and processes used in metabolomics, we will review the main research on this subject by focusing specifically on in vitro proton nuclear magnetic resonance spectroscopy based metabolomics approaches in human studies. We will first consider the clinical point of view enlighten physicians on this new approach and emphasis its future use in clinical “routine”. Metabolomics is defined as the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification. It is an "omics" technique that is situated downstream of genomics, transcriptomics and proteomics. Metabolomics is recognized as a promising technique in the field of systems biology for the evaluation of global metabolic changes. During the last decade, metabolomics approaches have become widely used in the study of liver diseases for the detection of early biomarkers and altered metabolic pathways. It is a powerful technique to improve our pathophysiological knowledge of various liver diseases. It can be a useful tool to help clinicians in the diagnostic process especially to distinguish malignant and non-malignant liver disease as well as to determine the etiology or severity of the liver disease. It can also assess therapeutic response or predict drug induced liver injury. Nevertheless, the usefulness of metabolomics is often not understood by clinicians, especially the concept of metabolomics profiling or fingerprinting. In the present work, after a concise description of the different techniques and processes used in metabolomics, we will review the main research on this subject by focusing specifically on in vitro proton nuclear magnetic resonance spectroscopy based metabolomics approaches in human studies. We will first consider the clinical point of view enlighten physicians on this new approach and emphasis its future use in clinical "routine".Metabolomics is defined as the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification. It is an "omics" technique that is situated downstream of genomics, transcriptomics and proteomics. Metabolomics is recognized as a promising technique in the field of systems biology for the evaluation of global metabolic changes. During the last decade, metabolomics approaches have become widely used in the study of liver diseases for the detection of early biomarkers and altered metabolic pathways. It is a powerful technique to improve our pathophysiological knowledge of various liver diseases. It can be a useful tool to help clinicians in the diagnostic process especially to distinguish malignant and non-malignant liver disease as well as to determine the etiology or severity of the liver disease. It can also assess therapeutic response or predict drug induced liver injury. Nevertheless, the usefulness of metabolomics is often not understood by clinicians, especially the concept of metabolomics profiling or fingerprinting. In the present work, after a concise description of the different techniques and processes used in metabolomics, we will review the main research on this subject by focusing specifically on in vitro proton nuclear magnetic resonance spectroscopy based metabolomics approaches in human studies. We will first consider the clinical point of view enlighten physicians on this new approach and emphasis its future use in clinical "routine". |
| Author | Amathieu, Roland |
| Author_xml | – sequence: 1 givenname: Roland surname: Amathieu fullname: Amathieu, Roland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26755887$$D View this record in MEDLINE/PubMed https://univ-evry.hal.science/hal-02489949$$DView record in HAL |
| BookMark | eNp1kcGP1CAYxYlZ486OXj0ajnpoBUoLeDDZbNQ1mWhi9Ewo_WaWDYUR2hr_e6mza3QTTxC-9973wu8CnYUYAKHnlNSN4PL1j9tDvTBWO1pzKh6hDWNUVUxycoY2lBBRqYaJc3SR8y0hrGla9gSds060rZRig9Kn2XowCY_mEGByFifIMZhgAfcmw4BHmEwffRydzdiEAXu3QMKDy1Dm-Q3-AhbChM2wrK6TZj9PcwJsvQvOGo_N8ejLZXIx5Kfo8d74DM_uzi369v7d16vravf5w8ery11lOeNTZYnlHAQFIKbpVW8NN4QNQ98ZI2jbK9sPQyMVAbFXpAXJW9spao1kqgcKzRa9PeUe536EYS2ZjNfH5EaTfuponP53EtyNPsRF807JlvAS8OoUcPPAdn250-sbYVwqxdVCi_bl3bIUv8-QJz26bMF7EyDOWVPREdm2K4ItevF3rz_J91CKgJ8ENsWcE-y1ddPvvys1ndeU6JW9Lux1Ya8d1YV9sdUPbPfJ_zH8ApZNtfQ |
| CitedBy_id | crossref_primary_10_3390_ijms24032409 crossref_primary_10_1080_17474124_2018_1453356 crossref_primary_10_1371_journal_pone_0155094 crossref_primary_10_4254_wjh_v15_i9_1043 crossref_primary_10_1002_cpdd_310 crossref_primary_10_1016_j_trac_2017_09_015 crossref_primary_10_1186_s13071_021_04807_1 crossref_primary_10_1016_j_aquaculture_2021_737451 crossref_primary_10_1016_j_biopha_2021_112217 crossref_primary_10_1038_s41598_021_91164_9 crossref_primary_10_1038_s41598_022_09056_5 crossref_primary_10_1097_MPG_0000000000001203 crossref_primary_10_1093_jbcr_iraa209 crossref_primary_10_1002_bmc_5859 crossref_primary_10_1158_1055_9965_EPI_21_0687 crossref_primary_10_3390_metabo14080407 crossref_primary_10_3892_br_2017_868 crossref_primary_10_1038_s41598_020_63252_9 crossref_primary_10_1039_C7RA13616A crossref_primary_10_1016_j_cca_2018_04_022 crossref_primary_10_1016_j_fct_2017_02_030 crossref_primary_10_1093_femsle_fnab038 crossref_primary_10_18632_oncotarget_19173 crossref_primary_10_1371_journal_pone_0182767 crossref_primary_10_1097_HEP_0000000000000341 crossref_primary_10_1038_s41598_017_00944_9 crossref_primary_10_1016_j_tiv_2024_105881 crossref_primary_10_1186_s13071_019_3554_0 crossref_primary_10_1016_j_jep_2023_117482 crossref_primary_10_1038_s41598_017_11759_z crossref_primary_10_1007_s00204_018_2286_9 crossref_primary_10_1038_s41598_019_51493_2 crossref_primary_10_3390_diagnostics13142418 crossref_primary_10_1080_05704928_2023_2165091 crossref_primary_10_4254_wjh_v10_i1_105 |
| Cites_doi | 10.1080/0031302021000009324 10.1146/annurev.anchem.1.031207.113026 10.1111/j.1478-3231.2008.01934.x 10.1016/j.jhep.2009.11.002 10.1021/pr200265z 10.1097/01.tp.0000251649.01148 10.1016/j.cell.2008.08.026 10.1371/journal.pone.0016957 10.1038/clpt.2009.240 10.1021/pr100486e 10.1073/pnas.0904489106 10.1111/j.1365-2893.2009.01252.x 10.1021/pr901058t 10.1111/j.1365-2893.2011.01488.x 10.3748/wjg.v18.i3.285 10.1111/j.1349-7006.2009.01086.x 10.1021/pr101096f 10.2217/14622416.6.7.691 10.1021/pr070063h 10.3892/ijmm.2010.563 10.1093/nar/gkl923 10.1002/nbm.1034 10.1016/j.jhep.2009.10.006 10.1038/nrm1451 10.1021/pr500462f 10.1097/00007890-200109150-00020 10.3109/13547500903261354 10.1002/hep.510310201 10.1002/nbm.1005 10.1371/journal.pone.0089230 10.1039/b418288j 10.1021/pr060591d 10.1158/1078-0432.CCR-12-1099 10.1111/j.1477-2574.2010.00185.x 10.1039/b906712b 10.1111/j.1478-3231.2006.01283.x 10.1111/j.1872-034X.2011.00964.x 10.1007/s11306-007-0081-3 10.1021/pr060594q |
| ContentType | Journal Article |
| Copyright | Distributed under a Creative Commons Attribution 4.0 International License The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. 2016 |
| Copyright_xml | – notice: Distributed under a Creative Commons Attribution 4.0 International License – notice: The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. 2016 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC VOOES 5PM |
| DOI | 10.3748/wjg.v22.i1.417 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2219-2840 |
| EndPage | 426 |
| ExternalDocumentID | PMC4698504 oai_HAL_hal_02489949v1 26755887 10_3748_wjg_v22_i1_417 |
| Genre | Journal Article Review |
| GroupedDBID | --- 123 29R 2WC 36B 53G 5VR 8WL 92F 92I AAKDD AAYXX ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CHBEP CIEJG CITATION CS3 CW9 DIK DU5 E3Z EBS EJD F5P FA0 FRP GX1 HYE OK1 P2P RNS RPM TCJ TGQ TR2 WFFXF XSB CGR CUY CVF ECM EIF M~E NPM 7X8 1XC VOOES 5PM |
| ID | FETCH-LOGICAL-c424t-c0c44e71ee0a3b9bca4a02ddb6aa715b9cbdd3890e7f905e845c691ca829be1e3 |
| ISSN | 1007-9327 2219-2840 |
| IngestDate | Thu Aug 21 13:36:47 EDT 2025 Fri May 09 12:25:33 EDT 2025 Fri Jul 11 02:02:35 EDT 2025 Thu Jan 02 22:17:58 EST 2025 Thu Apr 24 23:08:20 EDT 2025 Tue Jul 01 01:54:08 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Cirrhosis Metabolomics Liver diseases In vitro nuclear magnetic resonance spectroscopy |
| Language | English |
| License | Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c424t-c0c44e71ee0a3b9bca4a02ddb6aa715b9cbdd3890e7f905e845c691ca829be1e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 PMCID: PMC4698504 Telephone: +33-1-48026680 Fax: +33-1-48026675 Correspondence to: Roland Amathieu, MD, PhD, Assitance Publique des Hôpitaux de Paris (AP-HP), Réanimation polyvalente, Hôpital Universitaire Jean Verdier, Allée du 14 Juillet, Bondy, 93140 Bondy, France. roland.amathieu@aphp.fr Author contributions: All authors contributed to this manuscript. |
| OpenAccessLink | https://univ-evry.hal.science/hal-02489949 |
| PMID | 26755887 |
| PQID | 1760855002 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4698504 hal_primary_oai_HAL_hal_02489949v1 proquest_miscellaneous_1760855002 pubmed_primary_26755887 crossref_citationtrail_10_3748_wjg_v22_i1_417 crossref_primary_10_3748_wjg_v22_i1_417 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2016-01-07 |
| PublicationDateYYYYMMDD | 2016-01-07 |
| PublicationDate_xml | – month: 01 year: 2016 text: 2016-01-07 day: 07 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | World journal of gastroenterology : WJG |
| PublicationTitleAlternate | World J Gastroenterol |
| PublicationYear | 2016 |
| Publisher | Baishideng Publishing Group Co. Limited Baishideng Publishing Group Inc |
| Publisher_xml | – name: Baishideng Publishing Group Co. Limited – name: Baishideng Publishing Group Inc |
| References | ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 21359215 - PLoS One. 2011;6(2):e16957 20036026 - J Hepatol. 2010 Feb;52(2):228-33 19469021 - Cancer Sci. 2009 Apr;100(4):782-5 24940827 - J Proteome Res. 2014 Jun 30;:null 17269704 - J Proteome Res. 2007 Feb;6(2):469-79 21072494 - Int J Mol Med. 2011 Jan;27(1):111-7 21568267 - J Proteome Res. 2011 Jul 1;10(7):3239-45 19780643 - Biomarkers. 2009 Dec;14(8):572-86 20662790 - HPB (Oxford). 2010 Aug;12(6):396-402 15852128 - Analyst. 2005 May;130(5):606-25 24586615 - PLoS One. 2014;9(2):e89230 19207969 - Liver Int. 2009 Jan;29 Suppl 1:74-81 15340383 - Nat Rev Mol Cell Biol. 2004 Sep;5(9):763-9 17539670 - J Proteome Res. 2007 Jul;6(7):2413-9 20717559 - Chem Soc Rev. 2011 Jan;40(1):387-426 20070502 - J Viral Hepat. 2010 Dec;17(12):854-8 16842327 - Liver Int. 2006 Aug;26(6):703-7 19913320 - J Hepatol. 2010 Jan;52(1):16-24 16598697 - NMR Biomed. 2006 Aug;19(5):521-6 20182423 - Clin Pharmacol Ther. 2010 Jul;88(1):45-51 16207146 - Pharmacogenomics. 2005 Oct;6(7):691-9 23136190 - Clin Cancer Res. 2012 Dec 15;18(24):6714-22 17318087 - Transplantation. 2007 Feb 27;83(4):517-21 19667173 - Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14728-33 22404306 - Hepatol Res. 2012 Jul;42(7):677-85 10655244 - Hepatology. 2000 Feb;31(2):255-60 20690770 - J Proteome Res. 2010 Oct 1;9(10):5180-7 17202168 - Nucleic Acids Res. 2007 Jan;35(Database issue):D521-6 19968328 - J Proteome Res. 2010 Feb 5;9(2):1096-103 21914081 - J Viral Hepat. 2011 Oct;18(10):e591-602 11571450 - Transplantation. 2001 Sep 15;72(5):855-60 18775301 - Cell. 2008 Sep 5;134(5):714-7 16411169 - NMR Biomed. 2006 Feb;19(1):90-100 17564425 - J Proteome Res. 2007 Jul;6(7):2605-14 12408339 - Pathology. 2002 Oct;34(5):417-22 22294833 - World J Gastroenterol. 2012 Jan 21;18(3):285-90 21275434 - J Proteome Res. 2011 Apr 1;10(4):1828-36 20636074 - Annu Rev Anal Chem (Palo Alto Calif). 2008;1:45-69 |
| References_xml | – ident: ref32 doi: 10.1080/0031302021000009324 – ident: ref1 doi: 10.1146/annurev.anchem.1.031207.113026 – ident: ref18 doi: 10.1111/j.1478-3231.2008.01934.x – ident: ref33 doi: 10.1016/j.jhep.2009.11.002 – ident: ref20 doi: 10.1021/pr200265z – ident: ref34 doi: 10.1097/01.tp.0000251649.01148 – ident: ref10 doi: 10.1016/j.cell.2008.08.026 – ident: ref4 doi: 10.1371/journal.pone.0016957 – ident: ref14 doi: 10.1038/clpt.2009.240 – ident: ref26 doi: 10.1021/pr100486e – ident: ref13 doi: 10.1073/pnas.0904489106 – ident: ref19 doi: 10.1111/j.1365-2893.2009.01252.x – ident: ref31 doi: 10.1021/pr901058t – ident: ref36 doi: 10.1111/j.1365-2893.2011.01488.x – ident: ref25 doi: 10.3748/wjg.v18.i3.285 – ident: ref28 doi: 10.1111/j.1349-7006.2009.01086.x – ident: ref30 doi: 10.1021/pr101096f – ident: ref12 doi: 10.2217/14622416.6.7.691 – ident: ref39 doi: 10.1021/pr070063h – ident: ref22 doi: 10.3892/ijmm.2010.563 – ident: ref7 doi: 10.1093/nar/gkl923 – ident: ref15 doi: 10.1002/nbm.1034 – ident: ref40 doi: 10.1016/j.jhep.2009.10.006 – ident: ref2 doi: 10.1038/nrm1451 – ident: ref6 – ident: ref17 doi: 10.1021/pr500462f – ident: ref35 doi: 10.1097/00007890-200109150-00020 – ident: ref37 doi: 10.3109/13547500903261354 – ident: ref11 doi: 10.1002/hep.510310201 – ident: ref21 doi: 10.1002/nbm.1005 – ident: ref27 doi: 10.1371/journal.pone.0089230 – ident: ref9 doi: 10.1039/b418288j – ident: ref23 doi: 10.1021/pr060591d – ident: ref29 doi: 10.1158/1078-0432.CCR-12-1099 – ident: ref38 doi: 10.1111/j.1477-2574.2010.00185.x – ident: ref3 doi: 10.1039/b906712b – ident: ref16 doi: 10.1111/j.1478-3231.2006.01283.x – ident: ref24 doi: 10.1111/j.1872-034X.2011.00964.x – ident: ref5 doi: 10.1007/s11306-007-0081-3 – ident: ref8 doi: 10.1021/pr060594q – reference: 21914081 - J Viral Hepat. 2011 Oct;18(10):e591-602 – reference: 11571450 - Transplantation. 2001 Sep 15;72(5):855-60 – reference: 10655244 - Hepatology. 2000 Feb;31(2):255-60 – reference: 16207146 - Pharmacogenomics. 2005 Oct;6(7):691-9 – reference: 20662790 - HPB (Oxford). 2010 Aug;12(6):396-402 – reference: 20036026 - J Hepatol. 2010 Feb;52(2):228-33 – reference: 15340383 - Nat Rev Mol Cell Biol. 2004 Sep;5(9):763-9 – reference: 21359215 - PLoS One. 2011;6(2):e16957 – reference: 17564425 - J Proteome Res. 2007 Jul;6(7):2605-14 – reference: 20636074 - Annu Rev Anal Chem (Palo Alto Calif). 2008;1:45-69 – reference: 17202168 - Nucleic Acids Res. 2007 Jan;35(Database issue):D521-6 – reference: 24940827 - J Proteome Res. 2014 Jun 30;:null – reference: 18775301 - Cell. 2008 Sep 5;134(5):714-7 – reference: 19469021 - Cancer Sci. 2009 Apr;100(4):782-5 – reference: 19207969 - Liver Int. 2009 Jan;29 Suppl 1:74-81 – reference: 17318087 - Transplantation. 2007 Feb 27;83(4):517-21 – reference: 22294833 - World J Gastroenterol. 2012 Jan 21;18(3):285-90 – reference: 20717559 - Chem Soc Rev. 2011 Jan;40(1):387-426 – reference: 15852128 - Analyst. 2005 May;130(5):606-25 – reference: 21568267 - J Proteome Res. 2011 Jul 1;10(7):3239-45 – reference: 20182423 - Clin Pharmacol Ther. 2010 Jul;88(1):45-51 – reference: 12408339 - Pathology. 2002 Oct;34(5):417-22 – reference: 19780643 - Biomarkers. 2009 Dec;14(8):572-86 – reference: 21275434 - J Proteome Res. 2011 Apr 1;10(4):1828-36 – reference: 21072494 - Int J Mol Med. 2011 Jan;27(1):111-7 – reference: 20690770 - J Proteome Res. 2010 Oct 1;9(10):5180-7 – reference: 20070502 - J Viral Hepat. 2010 Dec;17(12):854-8 – reference: 16411169 - NMR Biomed. 2006 Feb;19(1):90-100 – reference: 23136190 - Clin Cancer Res. 2012 Dec 15;18(24):6714-22 – reference: 19968328 - J Proteome Res. 2010 Feb 5;9(2):1096-103 – reference: 17269704 - J Proteome Res. 2007 Feb;6(2):469-79 – reference: 19667173 - Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14728-33 – reference: 22404306 - Hepatol Res. 2012 Jul;42(7):677-85 – reference: 16598697 - NMR Biomed. 2006 Aug;19(5):521-6 – reference: 19913320 - J Hepatol. 2010 Jan;52(1):16-24 – reference: 17539670 - J Proteome Res. 2007 Jul;6(7):2413-9 – reference: 16842327 - Liver Int. 2006 Aug;26(6):703-7 – reference: 24586615 - PLoS One. 2014;9(2):e89230 |
| SSID | ssj0023352 |
| Score | 2.352981 |
| SecondaryResourceType | review_article |
| Snippet | Metabolomics is defined as the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or... |
| SourceID | pubmedcentral hal proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 417 |
| SubjectTerms | Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - metabolism Chemical and Drug Induced Liver Injury - diagnosis Chemical and Drug Induced Liver Injury - metabolism Hepatitis C, Chronic - diagnosis Hepatitis C, Chronic - metabolism Hepatitis, Autoimmune - diagnosis Hepatitis, Autoimmune - metabolism Humans Life Sciences Liver Cirrhosis - diagnosis Liver Cirrhosis - metabolism Liver Diseases - diagnosis Liver Diseases - metabolism Liver Failure, Acute - diagnosis Liver Failure, Acute - metabolism Liver Neoplasms - diagnosis Liver Neoplasms - metabolism Liver Transplantation Metabolomics - methods Metabolomics - trends Minireviews Proton Magnetic Resonance Spectroscopy - methods |
| Title | Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/26755887 https://www.proquest.com/docview/1760855002 https://univ-evry.hal.science/hal-02489949 https://pubmed.ncbi.nlm.nih.gov/PMC4698504 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa68cILAnELNxmExANKiR0njnmrEKiqYE-b2FtkO05X1KUoa4fEr-ecOMmSbkiDl6hKfWlzvtjn2J-_Q8hbncba2pKFmdEQoJhMhMppTPdikQoVM9Mo8H07SucnYnGanE4miwFrabc1U_v7xnMl_2NVuAd2xVOy_2DZvlG4AZ_BvnAFC8P1VjY-QjFiXb8_18vKeTFm9KzxXcXZqcD80GDkNZ489lrMa6RhdLsyLRvONjRzzwXwpbzQyNWpyeEu99Cb9UycgfjEUl9s6w3KfNZe2wl7-L7o83fNzpHs6Hae091mD-lXHZhfdZCDgRKXOMH3k8ORlPNriPHDovDnM_eHa5S-gWf868dyesn5dMWmbcGxLvbefNWzCCF-wRZyqJ9D_XzFcqh_QO5wCBnibuWmDb7xbFmz893-bi_gifU_jPsfOSgHZ0iPvR577FNoBz7J8X1yrw0m6Mwj4wGZuOohqVtU0A4VtEcFbVBBh6igYAPaoIJ2qPhIPSZoh4mmjMcE7TBBh5h4RE6-fD7-NA_bzBqhFVxsQxtZIZxkzkU6NspYLXTEi8KkWkuWGGVNUYArGzlZqihxmUhsqpjVGVfGMRc_JofVpnJPCbWpK0sIYmUZM2HiUsky1VmWCimgRsEDEnaPM7et7DxmP1nnN5svIO_68j-94MpfS74B6_SFUCd9Pvua4z0U6lNKqEsWkNed8XIYOHE3TFdus7vImUyRownQCMgTb8y-LQ5hdALTb0DkyMyjzsbfVKuzRpwdM7ImkXh267_xnNy9esFekMNtvXMvwdHdmlcNgv8A6DWx3g |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nuclear+magnetic+resonance+based+metabolomics+and+liver+diseases%3A+Recent+advances+and+future+clinical+applications&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Amathieu%2C+Roland&rft.date=2016-01-07&rft.issn=1007-9327&rft.volume=22&rft.issue=1&rft.spage=417&rft_id=info:doi/10.3748%2Fwjg.v22.i1.417&rft.externalDBID=n%2Fa&rft.externalDocID=10_3748_wjg_v22_i1_417 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1007-9327&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1007-9327&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1007-9327&client=summon |